Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

N/ANon-phased studies

2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(1)

Detailed Status

Completed2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed267%

unknown133%

Recent Activity

0 active trials

Showing 3 of 3

completednot_applicable

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

NCT03948724

unknownnot_applicable

Effects of Preparatory Information on Anxiety and Treatment Adherence in Heart Surgery Patients

NCT06201117

completed

Evaluation of the Information of the Patient Before a Scheduled Coronarography

NCT02484144

Clinical Trials (3)

Showing 3 of 3 trials

NCT03948724Not Applicable

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Completed

NCT06201117Not Applicable

Effects of Preparatory Information on Anxiety and Treatment Adherence in Heart Surgery Patients

Unknown

NCT02484144

Evaluation of the Information of the Patient Before a Scheduled Coronarography

Completed

All 3 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 3